Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
When tissues are damaged, normal tissue architecture may be replaced by excess ECM, a process called fibrosis
The right medication depends on your health history, your goals, how your body tolerates treatment, and what your coverage supports
Presented for research literature review only Stewart CP et al
The Wegovy protocol, the FDA-approved formulation for weight loss, uses this progression: 0.25mg for weeks 1 through 4, 0.5mg for weeks 5 through 8, 1.0mg for weeks 9 through 12, 1.7mg for weeks 13 through 16, and finally 2.4mg from week 17 onward
If youre unsure, check with your healthcare provider for guidance
Inclusion Criteria Exclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive weekly subcutaneous injections of either CagriSema or Tirzepatide, with a dose escalation period followed by maintenance dosing Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
US$ 23.20
US$ 25.09
US$ 23.92
US$ 29.06
US$ 21.72
US$ 28.35
US$ 27.92
